Valeant Pharmaceuticals Intern... : VRX

All VRX Articles

185 Articles

Jon C. Ogg | Jan 24, 2018 at 9:20 AM EST

Top Analyst Upgrades and Downgrades: Cree, Home Depot, Kimberly-Clark, Microsoft, Oracle, Valeant, Valero and More

The top analyst upgrades, downgrades and other research calls from Wednesday include Cree, Home Depot, Kimberly-Clark, Microsoft, Oracle, Valeant Pharmaceuticals…

Chris Lange | Dec 18, 2017 at 1:35 PM EST

Valeant Pharmaceuticals Well on the Road to Recovery After Bausch + Lomb Distribution Deal

Valeant Pharmaceuticals shares made a spectacular crash over the course of 2015 to 2017, and it looks like they may…

Lee Jackson | Dec 15, 2017 at 9:05 AM EST

Top Analyst Upgrades and Downgrades: Delta Air Lines, Express Scripts, Form Factor, Marathon Oil, Under Armour, Valeant Pharmaceuticals and More

The include Delta Air Lines, Express Scripts, Form Factor, Marathon Oil, Under Armour and Valeant Pharmaceutical.

Paul Ausick | Nov 7, 2017 at 8:30 AM EST

Valeant Earnings Soar on Tax Benefit

Drug maker Valeant got a big profit boost from a one-time tax benefit and the company also boosted its EPS…

Chris Lange | Nov 5, 2017 at 10:15 AM EST

CenturyLink, Disney, JC Penney and More Major Earnings Coming This Week

Most of the earnings season has come and gone but there are still some major companies posting results this week.

Chris Lange | Oct 28, 2017 at 10:05 AM EDT

Top Biopharma Events Coming by the End of 2017

24/7 Wall St. has collected a few pharma and biotech catalysts that are coming up on the calendar in November…

Chris Lange | Aug 17, 2017 at 12:15 PM EDT

Valeant Pharmaceuticals Gets Boost From FDA Update

Valeant Pharmaceuticals International, Inc. (NYSE: VRX) saw its shares make a handy gain on Thursday after the company provided an…

Chris Lange | Aug 8, 2017 at 11:05 AM EDT

Is This the Turnaround Valeant Pharma Has Been Waiting For?

Valeant Pharmaceuticals reported mixed second-quarter financial results before the markets opened on Tuesday.

Chris Lange | Aug 6, 2017 at 10:20 AM EDT

Disney, Snap and More of the Top Earnings to Watch This Week

24/7 Wall St. has put together a preview of a few major companies scheduled to report their quarterly results this…

Chris Lange | Jun 8, 2017 at 11:30 AM EDT

Valeant Pharmaceuticals Plans to Sell iNova Segment

Valeant Pharmaceuticals shares made a solid gain on Thursday after the company announced the sale of its iNova Pharmaceutical business.

Chris Lange | May 9, 2017 at 12:05 PM EDT

Is Valeant for Real This Time?

With earnings this positive and shares responding as a result, investors have to wonder if Valeant Pharmaceuticals is for real…

Paul Ausick | May 9, 2017 at 7:45 AM EDT

How Valeant Earnings Beat Estimates

Canadian pharmaceutical maker Valeant posted a big beat on both earnings and revenues Tuesday morning. The company also raised its…

Chris Lange | May 7, 2017 at 10:25 AM EDT

Disney, Snap, Whole Foods and More Key Earnings Reports Coming This Week

24/7 Wall St. has put together a preview of Disney, Valeant Pharmaceuticals and a other major companies scheduled to report…

Jon C. Ogg | May 1, 2017 at 12:05 PM EDT

Valeant Still Has a Long Way to Go on Paying Down Its Debt

Following the closing of the sale of three skincare brands to L'Oréal and after the closing of the divestiture of…

Paul Ausick | Apr 24, 2017 at 4:04 PM EDT

Rite Aid, DryShips Stumble into Monday’s 52-Week Low Club

Rite Aid, DryShips, Mattel, and Valeant all posted new 52-week lows on Monday.

1 2 3 4 … 13

Valeant Pharmaceuticals Intern... : VRX

All VRX Articles

Top Analyst Upgrades and Downgrades: Cree, Home Depot, Kimberly-Clark, Microsoft, Oracle, Valeant, Valero and More

Valeant Pharmaceuticals Well on the Road to Recovery After Bausch + Lomb Distribution Deal

Top Analyst Upgrades and Downgrades: Delta Air Lines, Express Scripts, Form Factor, Marathon Oil, Under Armour, Valeant Pharmaceuticals and More

Valeant Earnings Soar on Tax Benefit

CenturyLink, Disney, JC Penney and More Major Earnings Coming This Week

Top Biopharma Events Coming by the End of 2017

Valeant Pharmaceuticals Gets Boost From FDA Update

Is This the Turnaround Valeant Pharma Has Been Waiting For?

Disney, Snap and More of the Top Earnings to Watch This Week

Valeant Pharmaceuticals Plans to Sell iNova Segment

Is Valeant for Real This Time?

How Valeant Earnings Beat Estimates

Disney, Snap, Whole Foods and More Key Earnings Reports Coming This Week

Valeant Still Has a Long Way to Go on Paying Down Its Debt

Rite Aid, DryShips Stumble into Monday’s 52-Week Low Club

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

This High-Yield ETF Combines Bond Investing With Emerging Market Currencies

SoFi Stock Could Jump 26% as Market Overreacts to One Soft Segment

52% of Americans Are Building Wealth While Ignoring Their Greatest Risk

3 Reasons Retirees Should Not Enroll in Medicare Advantage for 2026

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

This High-Yield ETF Combines Bond Investing With Emerging Market Currencies

Valeant Pharmaceuticals Intern... : VRX

All VRX Articles

Top Analyst Upgrades and Downgrades: Cree, Home Depot, Kimberly-Clark, Microsoft, Oracle, Valeant, Valero and More

Valeant Pharmaceuticals Well on the Road to Recovery After Bausch + Lomb Distribution Deal

Top Analyst Upgrades and Downgrades: Delta Air Lines, Express Scripts, Form Factor, Marathon Oil, Under Armour, Valeant Pharmaceuticals and More

Valeant Earnings Soar on Tax Benefit

CenturyLink, Disney, JC Penney and More Major Earnings Coming This Week

Top Biopharma Events Coming by the End of 2017

Valeant Pharmaceuticals Gets Boost From FDA Update

Is This the Turnaround Valeant Pharma Has Been Waiting For?

Disney, Snap and More of the Top Earnings to Watch This Week

Valeant Pharmaceuticals Plans to Sell iNova Segment

Is Valeant for Real This Time?

How Valeant Earnings Beat Estimates

Disney, Snap, Whole Foods and More Key Earnings Reports Coming This Week

Valeant Still Has a Long Way to Go on Paying Down Its Debt

Rite Aid, DryShips Stumble into Monday’s 52-Week Low Club

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

This High-Yield ETF Combines Bond Investing With Emerging Market Currencies

SoFi Stock Could Jump 26% as Market Overreacts to One Soft Segment

Featured Reads

52% of Americans Are Building Wealth While Ignoring Their Greatest Risk

3 Reasons Retirees Should Not Enroll in Medicare Advantage for 2026